“Sizable Upside Potential”: 4 Aggressive Biotech And Life Sciences Plays Under $10
“These are four stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…
Upside Potential
5 Energy Stocks Under $10 For Aggressive Traders Looking For Solid Upside Potential
“With West Texas Intermediate (WTI) crude trading near the $70 a barrel level, and expected to go even higher this summer, these stocks could have…
These 4 Stocks Have Value Stock Metrics – And Momentum Stock Upside!
“These are four quality stocks to buy that have value characteristics but also appear to have the hidden potential to have momentum stock upside,” says…
A Strong Product Pipeline, Solid Upside And Attractive Valuation Could Make This Biotech A Buy
With nine FDA-approved products and more than 30 product candidates in clinical development – including a potential COVID-19 therapeutic – the biotechnology company featured in…
Wall Street Is “Pounding The Table” On This Sector – 5 Picks For Aggressive Investors
“With West Texas Intermediate (WTI) crude trading near the $60 a barrel level, and expected to go even higher this summer, these could all have…
5 Stocks Under $10 Offering Solid Alpha Potential For Aggressive Investors
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…
4 Under-$10 Biotech Stocks With Solid Upside Potential For Aggressive Traders
“Many investors, especially more aggressive traders, look at lower-priced stocks as a way to not only make some good money but to get a higher…
Battle Of The “Strong Buy” Biotechs
BioXcel Therapeutics is a clinical-stage biopharmaceutical company that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. TG Therapeutics is a biopharmaceutical company…
3 Biotech Stocks Flying High In The Mid-Cap “Sweet Spot”
In regards to biotech’s bullish year, the author of today’s article notes that “The COVID-19 pandemic has put a fire under many lesser-known names, including…
These 3 Biotechs Have Different Approaches To A COVID-19 Vaccine, But The Same Analyst Rating: ‘Buy’
An intranasal vaccine, an mRNA vaccine, and a T-cell activation vaccine: the three biotech companies discussed in today’s article are approaching the virus that causes…